Atlas Trials

HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease

Clinical trial NCT05813860 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05813860
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Crohn DiseaseInfliximab
Start date
2023-04-30
Primary completion
2026-05-31
Enrollment
976

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.